MediLink Announces Global Trial Collaboration And Supply Agreement
07 Oct 2024 //
PR NEWSWIRE
MediLink Presents YL201 Data At ESMO 2024 Showing Pan-Tumor Benefits
13 Sep 2024 //
PR NEWSWIRE
FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
19 Aug 2024 //
FIERCE BIOTECH
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
28 May 2024 //
ENDPTS
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
03 Jan 2024 //
PR NEWSWIRE